2 Matching Annotations
  1. Jul 2018
  2. europepmc.org europepmc.org
    https://www.ncbi.nlm.nih.gov/pubmed/25077823
    1
    1. PubMedCommonsArchive 02 Jul 2018

      On 2014 Sep 15, Amanda Capes-Davis commented:

      This study uses HEp-2 to investigate the role of CUGBP1 in laryngeal cancer. Please be aware that HEp-2 is known to be cross-contaminated with HeLa, which is from cervical cancer. These results do not relate to laryngeal cancer.

      Laboratories can test their cell line stocks for cross-contamination using a consensus method such as short tandem repeat (STR) profiling. For a list of known cross-contaminated cell lines, see http://iclac.org/databases/cross-contaminations/.

      This comment, imported by Hypothesis from PubMed Commons, is licensed under CC BY.
      PubMedCommonsArchive PMID:25077823
    Visit annotations in context

    Tags

    Annotators

    URL

    europepmc.org/abstract/MED/25077823
  3. Feb 2018
  4. europepmc.org europepmc.org
    https://www.ncbi.nlm.nih.gov/pubmed/25077823
    1
    1. PubMedCommonsArchive 09 Feb 2018

      On 2014 Sep 15, Amanda Capes-Davis commented:

      This study uses HEp-2 to investigate the role of CUGBP1 in laryngeal cancer. Please be aware that HEp-2 is known to be cross-contaminated with HeLa, which is from cervical cancer. These results do not relate to laryngeal cancer.

      Laboratories can test their cell line stocks for cross-contamination using a consensus method such as short tandem repeat (STR) profiling. For a list of known cross-contaminated cell lines, see http://iclac.org/databases/cross-contaminations/.

      This comment, imported by Hypothesis from PubMed Commons, is licensed under CC BY.
      PubMedCommonsArchive PMID:25077823
    Visit annotations in context

    Tags

    Annotators

    URL

    europepmc.org/abstract/MED/25077823